112 related articles for article (PubMed ID: 8143614)
1. K-ras oncogene codon 12 point mutations in testicular cancer.
Ridanpää M; Lothe RA; Onfelt A; Fosså S; Børresen AL; Husgafvel-Pursiainen K
Environ Health Perspect; 1993 Oct; 101 Suppl 3(Suppl 3):185-7. PubMed ID: 8143614
[TBL] [Abstract][Full Text] [Related]
2. K-ras codon 12 mutations in biliary tract tumors detected by polymerase chain reaction denaturing gradient gel electrophoresis.
Imai M; Hoshi T; Ogawa K
Cancer; 1994 Jun; 73(11):2727-33. PubMed ID: 8194013
[TBL] [Abstract][Full Text] [Related]
3. Detection of RAS mutations in archival testicular germ cell tumors by polymerase chain reaction and oligonucleotide hybridization.
Moul JW; Theune SM; Chang EH
Genes Chromosomes Cancer; 1992 Sep; 5(2):109-18. PubMed ID: 1381946
[TBL] [Abstract][Full Text] [Related]
4. Detection of ras gene mutations in human lung cancer: comparison of two screening assays based on the polymerase chain reaction.
Husgafvel-Pursiainen K; Ridanpää M; Hackman P; Anttila S; Karjalainen A; Onfelt A; Børresen AL; Vainio H
Environ Health Perspect; 1992 Nov; 98():183-5. PubMed ID: 1486847
[TBL] [Abstract][Full Text] [Related]
5. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
[TBL] [Abstract][Full Text] [Related]
6. K-RAS and N-RAS mutations in testicular germ cell tumors.
Hacioglu BM; Kodaz H; Erdogan B; Cinkaya A; Tastekin E; Hacibekiroglu I; Turkmen E; Kostek O; Genc E; Uzunoglu S; Cicin I
Bosn J Basic Med Sci; 2017 May; 17(2):159-163. PubMed ID: 28426398
[TBL] [Abstract][Full Text] [Related]
7. Denaturing gradient gel electrophoresis (DGGE) assay for K-ras and N-ras genes: detection of K-ras point mutations in human lung tumour DNA.
Ridanpää M; Husgafvel-Pursiainen K
Hum Mol Genet; 1993 Jun; 2(6):639-44. PubMed ID: 8353484
[TBL] [Abstract][Full Text] [Related]
8. Sporadic and Thorotrast-induced angiosarcomas of the liver manifest frequent and multiple point mutations in K-ras-2.
Przygodzki RM; Finkelstein SD; Keohavong P; Zhu D; Bakker A; Swalsky PA; Soini Y; Ishak KG; Bennett WP
Lab Invest; 1997 Jan; 76(1):153-9. PubMed ID: 9010458
[TBL] [Abstract][Full Text] [Related]
9. Primary mediastinal and testicular seminomas: a comparison of K-ras-2 gene sequence and p53 immunoperoxidase analysis of 26 cases.
Przygodzki RM; Moran CA; Suster S; Khan MA; Swalsky PA; Bakker A; Koss MN; Finkelstein SD
Hum Pathol; 1996 Sep; 27(9):975-9. PubMed ID: 8816895
[TBL] [Abstract][Full Text] [Related]
10. Detection of K-ras mutations by denaturing gradient gel electrophoresis (DGGE): a study on pancreatic cancer.
Pellegata NS; Losekoot M; Fodde R; Pugliese V; Saccomanno S; Renault B; Bernini LF; Ranzani GN
Anticancer Res; 1992; 12(5):1731-5. PubMed ID: 1444240
[TBL] [Abstract][Full Text] [Related]
11. Mutations of BRAF and RAS are rare events in germ cell tumours.
Sommerer F; Hengge UR; Markwarth A; Vomschloss S; Stolzenburg JU; Wittekind C; Tannapfel A
Int J Cancer; 2005 Jan; 113(2):329-35. PubMed ID: 15386408
[TBL] [Abstract][Full Text] [Related]
12. K-ras activation in premalignant and malignant epithelial lesions of the human uterus.
Enomoto T; Inoue M; Perantoni AO; Buzard GS; Miki H; Tanizawa O; Rice JM
Cancer Res; 1991 Oct; 51(19):5308-14. PubMed ID: 1913654
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients.
Rosell R; Li S; Skacel Z; Mate JL; Maestre J; Canela M; Tolosa E; Armengol P; Barnadas A; Ariza A
Oncogene; 1993 Sep; 8(9):2407-12. PubMed ID: 8395679
[TBL] [Abstract][Full Text] [Related]
14. A novel N-ras mutation in malignant melanoma is associated with excellent prognosis.
Demunter A; Ahmadian MR; Libbrecht L; Stas M; Baens M; Scheffzek K; Degreef H; De Wolf-Peeters C; van Den Oord JJ
Cancer Res; 2001 Jun; 61(12):4916-22. PubMed ID: 11406571
[TBL] [Abstract][Full Text] [Related]
15. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
[TBL] [Abstract][Full Text] [Related]
16. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
[TBL] [Abstract][Full Text] [Related]
17. K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients.
Zhu D; Keohavong P; Finkelstein SD; Swalsky P; Bakker A; Weissfeld J; Srivastava S; Whiteside TL
Cancer Res; 1997 Jun; 57(12):2485-92. PubMed ID: 9192830
[TBL] [Abstract][Full Text] [Related]
18. Detection of c-kit exons 11- and 17-activating mutations in testicular seminomas by high-resolution melting amplicon analysis.
Willmore-Payne C; Holden JA; Chadwick BE; Layfield LJ
Mod Pathol; 2006 Sep; 19(9):1164-9. PubMed ID: 16741525
[TBL] [Abstract][Full Text] [Related]
19. Detection of infrequent and multiple K-ras mutations in human tumors and tumor-adjacent tissues.
Keohavong P; Zhu D; Whiteside TL; Swalsky P; Bakker A; Elder EM; Siegfried JM; Srivastava S; Finkelstein SD
Anal Biochem; 1997 May; 247(2):394-403. PubMed ID: 9177704
[TBL] [Abstract][Full Text] [Related]
20. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]